Physician

Jason Robert Rothman, M.D.

According to 2025 Medicare claims, Jason Rothman, M.D. (NPI: 1730329699) practices urology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is TRIANGLE UROLOGY ASSOCIATES, P.A. (NPI: 1730181538; TIN: 561205950) and primary practice location at 27704-2125.

Rothman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 666 traditional Medicare patients, billed 6,838 HCPCS/CPT codes, and received $215,319 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,513 prescription claims across 598 beneficiaries totaling $819,873 in drug costs, led by Erleada (Apalutamide). DME data shows 53 claims. Open Payments data shows 91 records totaling $2,260. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $143,274 to $819,873. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $4,177 to $1,112.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	511	6,331	$159,217
2016	610	7,286	$169,641
2017	624	7,601	$180,128
2018	927	8,889	$354,592
2019	897	9,733	$229,289
2020	755	8,458	$224,905
2021	716	7,456	$223,539
2022	685	6,489	$214,157
2023	601	5,560	$211,185
2024	666	6,838	$215,319

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	332	1,646	$143,274
2016	380	1,901	$166,028
2017	423	2,001	$177,686
2018	556	2,475	$287,652
2019	608	2,646	$288,695
2020	554	2,480	$326,356
2021	572	2,541	$256,864
2022	590	2,582	$634,857
2023	559	2,436	$635,668
2024	598	2,513	$819,873

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	114	$11,088
2016	N/R	84	$11,723
2017	N/R	19	$3,593
2018	N/R	60	$11,610
2019	N/R	84	$29,189
2020	N/R	79	$40,752
2021	N/R	50	$7,713
2022	N/R	45	$26,193
2023	N/R	48	$30,759
2024	N/R	53	$37,355

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	381	512	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	233	279	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	182	186	$12
51798	Ultrasound measurement of bladder capacity after voiding	260	327	$8
81003	Automated urinalysis test	533	775	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	30	900	$424,761
Myrbetriq	Mirabegron	140	8,175	$119,059
Orgovyx	Relugolix	27	810	$69,646
Gemtesa	Vibegron	58	2,520	$39,418
Mirabegron Er	Mirabegron	13	1,110	$11,353

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	37	$35,478
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	16	$1,877

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	91	$2,260	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jason Robert Rothman, M.D.?

Tedicare shows public-source Medicare data for Jason Robert Rothman, M.D. (NPI 1730329699), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Robert Rothman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jason Robert Rothman, M.D.?

Jason Robert Rothman, M.D. is linked to TRIANGLE UROLOGY ASSOCIATES, P.A. (billing NPI 1730181538) in the available physician profile data.

Does Jason Robert Rothman, M.D. have Open Payments data?

Jason Robert Rothman, M.D. has 91 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.